• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $SRAX

    SRAX Inc.

    Subscribe to $SRAX
    $SRAX
    Advertising
    Consumer Discretionary

    SRAX, Inc., a technology company, focused on enhancing communications between public companies and their shareholders and investors in the United States. The company offers Sequire, a Saas platform that allows issuers to track their shareholders' behaviors and trends, then use data-driven insights to engage with shareholders across marketing channels. It also organizes and hosts investor conferences within the micro and small- cap space. The company markets and sells its services through its in-house sales and marketing team. The company was formerly known as Social Reality, Inc. and changed its name to SRAX, Inc. in August 2019. SRAX, Inc. was founded in 2009 and is headquartered in Westlake Village, California.

    IPO Year:

    Exchange: NASDAQ

    Website: srax.com

    Recent Analyst Ratings for SRAX Inc.

    DatePrice TargetRatingAnalyst
    See more ratings

    SRAX Inc. Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Dawson James initiated coverage on SRAX with a new price target

      Dawson James initiated coverage of SRAX with a rating of Buy and set a new price target of $10.00

      4/19/21 9:31:00 AM ET
      $SRAX
      Advertising
      Consumer Discretionary
    • B. Riley reiterated coverage on SRAX with a new price target

      B. Riley reiterated coverage of SRAX with a rating of Buy and set a new price target of $7.50 from $4.50 previously

      2/12/21 8:22:29 AM ET
      $SRAX
      Advertising
      Consumer Discretionary
    • Ladenburg Thalmann initiated coverage on SRAX with a new price target

      Ladenburg Thalmann initiated coverage of SRAX with a rating of Buy and set a new price target of $7.00

      2/8/21 7:58:16 AM ET
      $SRAX
      Advertising
      Consumer Discretionary
    • LADENBURG THALM/SH SH initiated coverage on SRAX

      LADENBURG THALM/SH SH initiated coverage of SRAX with a rating of Buy

      2/8/21 7:29:26 AM ET
      $SRAX
      Advertising
      Consumer Discretionary
    • B. Riley reiterated coverage on SRAX with a new price target

      B. Riley reiterated coverage of SRAX with a rating of Buy and set a new price target of $4.50 from $4.00 previously

      1/30/21 7:59:15 PM ET
      $SRAX
      Advertising
      Consumer Discretionary

    SRAX Inc. FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    See more
    • June 7, 2024 - FDA Roundup: June 7, 2024

      For Immediate Release: June 07, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced that it has advised the manufacturers of the licensed and authorized COVID-19 vaccines that the COVID-19 vaccines (2024-2025 Formula) for use in the United States should be monovalent (single strain) JN.1 vaccines to more closely match cu

      6/7/24 3:46:22 PM ET
      $GERN
      $SRAX
      $SNAP
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Advertising
      Consumer Discretionary
    • March 22, 2024 - FDA Roundup: March 22, 2024

      For Immediate Release: March 22, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued an emergency use authorization for Pemgarda (pemivibart) for the pre-exposure prophylaxis (prevention) of COVID-19 in certain adults and adolescents (12 years of age and older weighing at least 40 kilograms [about 88 pounds]).  Pemgarda is

      3/22/24 5:02:42 PM ET
      $SNAP
      $SRAX
      Computer Software: Programming Data Processing
      Technology
      Advertising
      Consumer Discretionary
    • November 9, 2023 - FDA Approves First Treatment for Patients with Rare Inherited Blood Clotting Disorder

      For Immediate Release: November 09, 2023 Today, the U.S. Food and Drug Administration approved Adzynma, the first recombinant (genetically engineered) protein product indicated for prophylactic (preventive) or on demand enzyme replacement therapy (ERT) in adult and pediatric patients with congenital thrombotic thrombocytopenic purpura (cTTP), a rare and life-threatening blood clotting disorder. “The FDA remains

      11/9/23 2:30:20 PM ET
      $SRAX
      $SNAP
      Advertising
      Consumer Discretionary
      Computer Software: Programming Data Processing
      Technology

    SRAX Inc. Press Releases

    Fastest customizable press release news feed in the world

    See more
    • SRAX Signs Agreement to Merge with DNA Holdings

      Westlake Village, CA, May 08, 2024 (GLOBE NEWSWIRE) -- SRAX Inc. (OTC:SRAX), a financial technology company that unlocks data and insights for publicly traded companies through its SaaS platform Sequire, announced today it has entered into a definitive merger agreement with DNA Holdings Venture Inc. pursuant to which the shareholders of DNA will become the majority owners of SRAX's outstanding common stock as more fully described below upon the closing of the merger. DNA has been a long term investor in SRAX and currently owns approximately 35% of the company.  DNA is  a Web3 investment company which provides both advisory services and invests in Web3 infrastructure. The company was foun

      5/8/24 8:00:00 AM ET
      $SRAX
      Advertising
      Consumer Discretionary
    • SRAX SELECTS XDEFI AS WEB3 WALLET PARTNER, ENABLING SECURE ACCESS TO DIGITAL ASSETS FOR ACTIVE EQUITY INVESTORS

      Los Angeles, March 05, 2024 (GLOBE NEWSWIRE) -- Los Angeles, [5 March 2024] - SRAX Inc. (OTC:SRAX), a financial technology company that unlocks data and insights for publicly traded companies through its SaaS platform Sequire, today announced it has selected XDEFI as its Web3 wallet partner. XDEFI is a pioneering multichain cryptocurrency wallet. The partnership will enable SRAX's network of active equity investors to access decentralized applications and assets spanning 200+ blockchains, seamlessly and securely. In addition, SRAX clients who download the wallet will be eligible for airdrops in $XDEFI tokens and many future token airdrops.  In 2023, over $5 billion was given away through

      3/5/24 8:30:00 AM ET
      $SRAX
      Advertising
      Consumer Discretionary
    • SRAX SHAREHOLDER LETTER

      Westlake Village, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Dear Shareholders, As I write to you today, I do so with a sense of deep reflection on the year that has passed. It's been a period that tested our resilience. I want to express my sincere regret for the concerns and frustrations you may have experienced as a result of our stock price. Addressing Our Challenges Head-On Our delisting from the NASDAQ market was a moment for serious introspection. Looking back, there were areas where we should have been more proactive, especially as it relates to our accounting team's leadership and the complexities of the accounting for our business.  Bringing in new experts was a turning point for th

      12/18/23 7:00:00 AM ET
      $SRAX
      Advertising
      Consumer Discretionary
    • SRAX Creates Advisory Board With Company's Largest Shareholders

      LOS ANGELES, July 17, 2023 (GLOBE NEWSWIRE) -- SRAX, Inc. (OTC:SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, announced today it has created an Advisory Board that is comprised of 4 of the company's largest shareholders. "SRAX has some amazing investors and we want to create a formal relationship with some of them so they can share their insights as we navigate getting our fillings back in order and restructure the business. These advisors are all very invested in the business, owning millions of shares collectively, and they all have a diverse background as it relates to small cap companies" Said Ch

      7/17/23 4:30:00 PM ET
      $SRAX
      Advertising
      Consumer Discretionary
    • RYVYL to Present at 13th Annual LD Micro Invitational

      SAN DIEGO, CA , May 30, 2023 (GLOBE NEWSWIRE) -- RYVYL Inc. (NASDAQ:RVYL) ("RYVYL" or the "Company"), a company that leverages the security of the blockchain and USD-pegged stablecoin technology with near-real-time attestation to conduct payment transactions announced today that management will present at the 13th Annual LD Micro Invitational on Wednesday, June 7, 2023 at the Luxe Sunset Boulevard Hotel in Los Angeles, California. Ben Errez, Chairman of RYVYL Inc., will conduct in-person one-on-one meetings throughout the conference and deliver the Company's presentation as shown below – which can be viewed live and via replay using the webcast link. 13th Annual LD Micro Invitational W

      5/30/23 8:00:00 AM ET
      $RVYL
      $SRAX
      Professional Services
      Consumer Discretionary
      Advertising
    • SRAX Inc. To Integrate GlobeNewswire Into the Sequire Platform

      LOS ANGELES, April 27, 2023 (GLOBE NEWSWIRE) -- SRAX, Inc. (OTC:SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, announced today it will integrate GlobeNewswire, a global news distribution service, to launch a self-serve press release feature through its investor intelligence and communications platform, Sequire The new feature will provide users with a streamlined experience, enabling them to quickly and easily create and distribute their press releases to the appropriate channels. Users will also have access to analytics that will allow them to track the performance of their releases and make data-

      4/27/23 9:00:00 AM ET
      $SRAX
      Advertising
      Consumer Discretionary
    • BitMine Immersion Technologies, Inc. to Present at the Sequire Investor Summit in Puerto Rico

      Atlanta, GA, April 25, 2023 (GLOBE NEWSWIRE) -- BitMine Immersion Technologies, Inc. (OTC:BMNR) is proud to announce its participation at the upcoming Sequire Investor Summit. This highly anticipated event, scheduled for April 24-26, 2023 at La Concha Resort in San Juan, Puerto Rico, promises to offer an array of exciting opportunities for funds, companies, and investors. One of the standout highlights of this year's summit is the focus on great tax laws in Puerto Rico, which offers a unique tax-friendly environment for both funds and investors. Attendees can expect to gain valuable insights and knowledge on how to leverage this advantage to drive their business success. The summit also

      4/25/23 1:37:14 PM ET
      $SRAX
      Advertising
      Consumer Discretionary
    • BioLargo to Present at the Sequire Investor Summit in Puerto Rico

      Westminster, CA, April 24, 2023 (GLOBE NEWSWIRE) -- BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable cleantech technologies and full-service environmental engineering company, announced its participation at the upcoming Sequire Investor Summit. This event is scheduled for April 24-26, 2023 at La Concha Resort in San Juan, Puerto Rico. BioLargo's presentation will take place at 11:30 AM Eastern on April 25, 2023. "We look forward to sharing the plans for our newly acquired sodium sulfur battery technology with conference attendees," said Dennis P. Calvert, CEO of BioLargo. "Our revenues grew by over 130% in 2022, and we intend to capitalize on this momentum in 2023 with the launch

      4/24/23 8:00:00 AM ET
      $SRAX
      Advertising
      Consumer Discretionary
    • Joseph Gunnar to Sponsor the Sequire Investor Summit in Puerto Rico

      Joseph Gunnar & Co., LLC ("JGUN"), a leading full service broker-dealer, investment adviser and investment bank, focused on the emerging growth markets, is proud to announce its sponsorship of the upcoming Sequire Investor Summit. This highly anticipated event, scheduled for April 24-26, 2023 at La Concha Resort in San Juan, Puerto Rico, promises to offer an array of exciting opportunities for funds, companies, and investors. One of the standout highlights of this year's summit is the focus on attractive tax laws in Puerto Rico, which offer a unique tax-friendly environment for both funds and investors. Attendees can expect to gain valuable insights and knowledge on how to leverage this a

      4/21/23 3:04:00 PM ET
      $SRAX
      Advertising
      Consumer Discretionary
    • BacTech to Present at the Sequire Investor Summit in Puerto Rico

      TORONTO, ON, April 20, 2023 (GLOBE NEWSWIRE) -- BacTech Environmental Corporation (CSE:BAC, OTC:BCCEF, FSE: 0BT1))) ("BacTech" or the "Company"), is pleased to announce its participation at the upcoming Sequire Investor Summit. This highly anticipated event, scheduled for April 24-26, 2023, at La Concha Resort in San Juan, Puerto Rico, promises to offer an array of exciting opportunities for funds, companies, and investors. The summit promises to offer comprehensive training sessions and keynote panels on various topics. These sessions are led by top experts in the field and provide attendees with a wealth of information and insights into the latest trends, strategies, and best practices

      4/20/23 2:08:31 PM ET
      $SRAX
      Advertising
      Consumer Discretionary

    SRAX Inc. SEC Filings

    See more
    • SEC Form 10-Q filed by SRAX Inc.

      10-Q - SRAX, Inc. (0001538217) (Filer)

      4/30/25 6:18:31 AM ET
      $SRAX
      Advertising
      Consumer Discretionary
    • SEC Form 10-Q filed by SRAX Inc.

      10-Q - SRAX, Inc. (0001538217) (Filer)

      3/7/25 6:03:29 AM ET
      $SRAX
      Advertising
      Consumer Discretionary
    • SEC Form 10-K filed by SRAX Inc.

      10-K - SRAX, Inc. (0001538217) (Filer)

      9/20/24 5:29:24 PM ET
      $SRAX
      Advertising
      Consumer Discretionary
    • SEC Form 8-K filed by SRAX Inc.

      8-K - SRAX, Inc. (0001538217) (Filer)

      5/13/24 11:34:08 AM ET
      $SRAX
      Advertising
      Consumer Discretionary
    • SRAX Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Events That Accelerate or Increase a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

      8-K - SRAX, Inc. (0001538217) (Filer)

      4/3/24 4:05:26 PM ET
      $SRAX
      Advertising
      Consumer Discretionary
    • SRAX Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

      8-K - SRAX, Inc. (0001538217) (Filer)

      4/2/24 4:05:41 PM ET
      $SRAX
      Advertising
      Consumer Discretionary
    • SRAX Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Events That Accelerate or Increase a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

      8-K - SRAX, Inc. (0001538217) (Filer)

      3/6/24 4:05:18 PM ET
      $SRAX
      Advertising
      Consumer Discretionary
    • SRAX Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Events That Accelerate or Increase a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

      8-K - SRAX, Inc. (0001538217) (Filer)

      11/6/23 5:15:25 PM ET
      $SRAX
      Advertising
      Consumer Discretionary
    • SEC Form 10-Q filed by SRAX Inc.

      10-Q - SRAX, Inc. (0001538217) (Filer)

      10/31/23 5:13:39 PM ET
      $SRAX
      Advertising
      Consumer Discretionary
    • SRAX Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

      8-K - SRAX, Inc. (0001538217) (Filer)

      9/19/23 5:07:22 PM ET
      $SRAX
      Advertising
      Consumer Discretionary